Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Summary of vaccine safety studies of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and their infants : supplementary table for: Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Filetype[PDF-48.10 KB]


You May Also Like:
  1. DTaP (Diphtheria, Tetanus, Pertussis) vaccine : what you need to know
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). National Center for Immunization and Respiratory Diseases (U.S.).
    Published Date:
    04/01/2020
    Series:
    Vaccine information statement (interim)
    Description:
    dtap.pdf
    File Type:
    Filetype[PDF - 129.91 KB]
  2. Tdap vaccine : what you need to know (Tetanus, Diphtheria and Pertussis)
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). National Center for Immunization and Respiratory Diseases (U.S.).
    Published Date:
    04/01/2020
    Series:
    Vaccine information statement (interim)
    Description:
    tdap.pdf
    File Type:
    Filetype[PDF - 152.51 KB]
  3. Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
    Personal Author:
    Oliver, Sara E.; Moore, Kelly L.;
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases.
    Published Date:
    February 07 2020
    Source:
    MMWR Morb Mortal Wkly Rep. 69(5):136-139
    Description:
    On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningococ...
    File Type:
    Filetype[PDF - 86.94 KB]
  4. Talking to pregnant women about vaccines
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    DECEMBER 2019
    Description:
    When talking to women about vaccines during pregnancy, make a strong recommendation and allow time for them to ask questions. Hearing your answers can help women feel more confident about protecting themselves and their babies with Tdap and flu vacci...
    File Type:
    Filetype[PDF - 73.57 KB]
  5. Safety of closely spaced Tdap vaccines in the catch-up immunization schedule
    Personal Author:
    Moro, Pedro L.
    Corporate Authors:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Immunization Safety Office.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 October 23-24, 2019 : Atlanta, GA)
    Published Date:
    October 23. 2019
    Series:
    ACIP meeting Pertussis Vaccines
    File Type:
    Filetype[PDF - 532.17 KB]